Literature DB >> 2215575

The diagnosis and prognosis of autosomal dominant polycystic kidney disease.

P S Parfrey1, J C Bear, J Morgan, B C Cramer, P J McManamon, M H Gault, D N Churchill, M Singh, R Hewitt, S Somlo.   

Abstract

BACKGROUND: Autosomal dominant polycystic kidney disease is usually caused by a mutant gene at the PKD1 locus on the short arm of chromosome 16, but in about 4 percent of families with the disorder it is caused by unknown mutations elsewhere in the genome. The natural course of the disease in both genetic forms is not well characterized.
METHODS: We studied 17 families with autosomal dominant polycystic kidney disease to compare presymptomatic diagnosis by ultrasonography with diagnosis by genetic-linkage studies and to relate clinical variation of the disease to whether the PKD1 mutation was implicated.
RESULTS: In 10 families the disorder was found to cosegregate with polymorphic DNA markers flanking the PKD1 locus, in 2 families it did not, and in 5 families linkage could not be determined. In the 10 families with the PKD1 mutation, 46 percent of the members less than 30 years old who had a 50 percent risk of inheriting a mutation had renal cysts, as compared with 11 percent of the members of the two families without linkage (P less than 0.001). In the PKD1 families, all 67 diagnoses made by ultrasonography were confirmed by determination of the genotype as inferred from linkage. Forty of 48 members (83 percent) less than 30 years old who inherited the PKD1 mutation had renal cysts. All 27 members 30 years old or older who inherited the mutation had renal cysts, suggesting that the probability of a false negative diagnosis did not exceed 0.13 in this age group (P less than 0.05). The mean (+/- SE) age at the onset of end-stage renal disease among members of the PKD1 families was 56.7 +/- 1.9 years, as compared with 69.4 +/- 1.7 years among members with cysts in the families without linkage (P = 0.0025). Hypertension and renal impairment were less frequent and occurred later in the families without the PKD1 mutation.
CONCLUSIONS: At present, in most persons with a 50 percent risk of autosomal dominant polycystic kidney disease, imaging techniques are the only mode of reaching a diagnosis before symptoms appear. In such persons a negative ultrasonographic study during early adult life indicates that the likelihood of inheriting a PKD1 mutation is small. In the few who inherit a non-PKD1 mutation for polycystic kidney disease, renal failure is likely to occur relatively late in life.

Entities:  

Mesh:

Year:  1990        PMID: 2215575     DOI: 10.1056/NEJM199010183231601

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  59 in total

1.  A spectrum of mutations in the second gene for autosomal dominant polycystic kidney disease (PKD2).

Authors:  B Veldhuisen; J J Saris; S de Haij; T Hayashi; D M Reynolds; T Mochizuki; R Elles; R Fossdal; N Bogdanova; M A van Dijk; E Coto; D Ravine; S Nørby; C Verellen-Dumoulin; M H Breuning; S Somlo; D J Peters
Journal:  Am J Hum Genet       Date:  1997-09       Impact factor: 11.025

2.  Genetic and clinical studies in autosomal dominant polycystic kidney disease type 1 (ADPKD1).

Authors:  E Coto; S Aguado; J Alvarez; M J Menéndez Díaz; C López-Larrea
Journal:  J Med Genet       Date:  1992-04       Impact factor: 6.318

3.  Phenotype recognition. Clinicians' contributions to molecular genetics.

Authors:  K D Gardner
Journal:  West J Med       Date:  1992-05

4.  Genetic heterogeneity and clinical disease.

Authors:  S T Reeders
Journal:  West J Med       Date:  1992-05

Review 5.  Diagnosis and management of childhood polycystic kidney disease.

Authors:  William E Sweeney; Ellis D Avner
Journal:  Pediatr Nephrol       Date:  2010-10-29       Impact factor: 3.714

6.  Four-dimensional MRI of renal function in the developing mouse.

Authors:  Luke Xie; Ergys Subashi; Yi Qi; Mark A Knepper; G Allan Johnson
Journal:  NMR Biomed       Date:  2014-07-26       Impact factor: 4.044

7.  Diagnosis of adult polycystic kidney disease by genetic markers and ultrasonographic imaging in a voluntary family register.

Authors:  R G Elles; K A Hodgkinson; N P Mallick; D J O'Donoghue; A P Read; S Rimmer; E A Watters; R Harris
Journal:  J Med Genet       Date:  1994-02       Impact factor: 6.318

8.  The HALT polycystic kidney disease trials: design and implementation.

Authors:  Arlene B Chapman; Vicente E Torres; Ronald D Perrone; Theodore I Steinman; Kyongtae T Bae; J Philip Miller; Dana C Miskulin; Frederic Rahbari Oskoui; Amirali Masoumi; Marie C Hogan; Franz T Winklhofer; William Braun; Paul A Thompson; Catherine M Meyers; Cass Kelleher; Robert W Schrier
Journal:  Clin J Am Soc Nephrol       Date:  2010-01       Impact factor: 8.237

Review 9.  Polycystic kidney diseases: from molecular discoveries to targeted therapeutic strategies.

Authors:  O Ibraghimov-Beskrovnaya; N Bukanov
Journal:  Cell Mol Life Sci       Date:  2008-02       Impact factor: 9.261

10.  Penetrance of HNPCC-related cancers in a retrolective cohort of 12 large Newfoundland families carrying a MSH2 founder mutation: an evaluation using modified segregation models.

Authors:  Karen A Kopciuk; Yun-Hee Choi; Elena Parkhomenko; Patrick Parfrey; John McLaughlin; Jane Green; Laurent Briollais
Journal:  Hered Cancer Clin Pract       Date:  2009-10-28       Impact factor: 2.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.